Brief: Orexo Launches Deprexis And Vorvida In The U.S. And Provides Updated Financial Guidance
02/07/2020 11:41
July 2 (Reuters) - Orexo AB ORX.ST :
* OREXO LAUNCHES DEPREXIS® AND VORVIDA® IN THE US AND
PROVIDES
UPDATED FINANCIAL GUIDANCE
Source text for Eikon: ID:nPn9vYbF8a
Further company coverage: ORX.ST
((Briefs@thomsonreuters.com;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens